Pfizer Breaks With Biosimilars In China Through WuXi Bio Deal

Pfizer China To Also Offload Manufacturing Site In Hangzhou

 
• By Dean Rudge
China globe
The agreement for the biologics site in Hangzhou is expected to close in the first half of 2021 • Source: Shutterstock

More from Biosimilars

More from Products